CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 73,336	$ 118,016
Short-term marketable securities	55,739	32,417
Related party receivables from collaborative arrangements	70,540	46,847
Prepaid expenses and other current assets	754	766
Total current assets	200,369	198,046
Property and equipment, net	209	368
Capitalized fees paid to a related party, net	166,722	180,545
Other assets	37	37
Total assets	367,337	378,996
Current liabilities:
Accounts payable	601	128
Accrued personnel-related expenses	1,721	2,361
Accrued interest payable	5,920	7,828
Other accrued liabilities	1,500	1,095
Current portion of long-term debt	25,000	7,752
Deferred revenue, current	0	885
Total current liabilities	34,742	20,049
Long-term debt, net of current portion, discount and issuance costs	574,362	708,341
Other long-term liabilities	940	1,383
Deferred revenue	0	2,214
Commitments and contingencies (Notes 9)
Stockholders' deficit:
Preferred stock: $0.01 par value, 230 shares authorized, no shares issued and outstanding
Common stock: $0.01 par value, 200,000 shares authorized, 102,046 and 108,585 shares issued as of December 31, 2017 and 2016, respectively	1,019	1,085
Treasury stock: 150 shares as of December 31, 2017 and 2016	(3,263)	(3,263)
Additional paid-in capital	1,258,151	1,282,077
Accumulated other comprehensive (loss) income	(18)	1
Accumulated deficit	(1,498,748)	(1,632,891)
Total Innoviva stockholders' deficit	(242,859)	(352,991)
Noncontrolling interest	152	0
Total stockholders' deficit	(242,707)	(352,991)
Total liabilities and stockholders' deficit	$ 367,337	$ 378,996